Beyond the Buzz Into the Core
Is the pharma market, which is currently at INR2.17 lakh crore (USD25.8 billion), getting too crowded? While some industry experts believe a few clear signs of fatigue have emerged, many say it is not a doom scenario yet and a rebound may not be far.
Glenn Saldanha, managing director and CEO, Glenmark pharmaceuticals; image credit: Agencies Synopsis Coping with a tough US generics business and…
Habil Khorakiwala, founder and chairman, Wockhardt Synopsis Wockhardt’s Habil Khorakiwala has seen the most harrowing days. From a payment default…
Private equity investors have been investing large sums of money in hospitals. Certain types of hospital chains are delivering healthy…